INTRODUCTION
Gastrointestinal bleeding (GIB) is a common condition in children and can occur in any area of the gastro intestinal tract, from the mouth to the anus. Fortunately, mortality for acute gastrointestinal bleeding (AGIB) is low in the pediatric population.
Over the last 10 years, there have been a number of improvements in diagnosis and management of GIB in general. Increased involvement has been seen in the management of AGIB and resuscitation and in the correct usage of diagnostic and therapeutic endoscopy. In addition, GIB cases have benefited from advances in diagnostic and therapeutic radiology techniques and equipment, as well as development of more selective and less invasive surgical approaches and of more efficacious, tolerable and safe ulcerhealing drugs. These changes have modified the diagnostic and treatment strategies for patients presenting with non variceal and variceal upper GIB (UGIB) and those with colonic bleeding.
The major objectives of GIB management are to reduce mortality and the need for major surgery. A secondary objective is to prevent unnecessary hospital admission for patients presenting with minor or selflimited bleeding. This position paper provides recommendations based on current evidence for best practice in the management of acute UGIB and lower GIB (LGIB) in children; management of patients over the age of 18 is not covered by this statement. This statement will be of interest for generalist and specialized pediatricians, as well as general medical professionals who may encounter pediatric patients among their patient population, such as acute phy sicians, gastroenterologists, gastrointestinal surgeons, endoscopists, pharmacists, anesthesiologists and nurses.
The statement presented herein resulted from a firstphase systematic literature search and review by experts comprising the "GastroPed Bleed Team" of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP). The preliminary draft was first circulated among the panel and a subsequent meeting was held, in which a consensus was reached on the points touched, resulting in the final statement that is presented herein. It is important to note that this position paper is not intended to be construed or to serve as a standard of care. Standards of care are determined on the basis of all clinical data available for an individual case and are subject to change as scientific knowledge and technology advances and patterns of care evolve.
DEFINITIONS
UGIB is that originating proximal to the ligament of Treitz, and, in practice, from the esophagus, stomach and duodenum.
LGIB is defined as bleeding distal to the ligament of Treitz. Hematemesis (and coffee ground vomitus) is vomiting of blood from the upper gastrointestinal tract or, occasionally, after swallowing blood from a source in the nasopharynx [1] . Bright red hematemesis usually implies active hemorrhage from the esophagus, stomach or duodenum. Coffeeground vomitus refers to the vomiting of black material, which is assumed to be blood. Melena is the passage of black tarry stools, usually due to acute UGIB but occasionally from bleeding within the small bowel or right side of the colon. Hematochezia is the passage of fresh or altered blood via rectum, usually due to colonic bleeding [2] . Shock is circulatory insufficiency, resulting in inadequate oxygen delivery that leads to global hypoperfusion and tissue hypoxia; in the context of GIB, shock is most likely to be hypovolemic (due to the inadequate circulating volume resulting from acute blood loss). Varices are abnormal distended veins, most frequently occurring in the esophagus (esophageal varices) and less frequently in the stomach (gastric varices) or other sites (ectopic varices), and usually occurring as a consequence of liver disease; variceal bleeding is characteristically severe and may be lifethreatening [3] . Endoscopy is the visualization of the inside of the gastrointestinal tract accomplished by means of videoscope. Examination of the upper gastrointestinal tract (esophagus, stomach and duodenum) is known as gastroscopy or upper gastrointestinal endoscopy. Examination of the colon (large bowel) is referred to as colonoscopy. A list of definitions is provided in Table 1 .
UGIB
In children, UGIB is an uncommon but potentially serious, lifethreatening clinical condition. From an anatomical perspective, the UGIB tract encompasses the gastrointestinal region from the esophagus to the ligament of Treitz [4] . A study by Cleveland et al [5] , involving 167 patients, showed the common signs and symptoms of UGIB at presentation to be hematemesis (73%), melena (21%) and coffeeground emesis (6%); however, patients may also experience epigastric pain, abdominal tenderness or dizziness.
The worldwide mortality rate for UGIB in children can range from 5% to 15%, reflecting the diverse populations that differentially experience conditions associated with UGIB, such as acute variceal hemorr hage [4, 6] . The causes of UGIB have been classified based upon variceal bleeding and nonvariceal bleeding ( Table 2 ) [7] . Case series reported from Asia and developing countries show a higher incidence of variceal bleeding [8] . The etiology of UGIB can be categorized by age groups, but causative disorders overlap considerably between these [4] . In newborns, the predominant causes include coagulation disorders, such as vitamin K deficiency, cow's milk protein allergy (CMPA) [9] , stressrelated gastritis, sepsis, and trauma from placement of nasogastric tubes. In infants (1 mo to endoscopy in UGIB are to identify the site of bleeding and to facilitate initiation of an appropriate therapeutic approach when indicated [5] . A flowchart of the diagnostic approach of UGIB is provided in Figure 1 . In summary, UGIB refers to bleeding above the ligament of Treitz and the priority of achieving a differential diagnosis addresses both the clinical presentation and the age of the patient.
LGIB
LGIB in children is a common clinical problem; indeed, it is reportedly the presenting complaint for approximately 0.3% of children in the emergency department [18] . In most cases, the bleeding is selflimiting, with the majority (80%) of LGIB cases in the emergency de partment undergoing routine discharge [19] . However, conditions such as Meckel's diverticulum, melena by variceal hemorrhages, acute intestinal obstruction or severe attack of ulcerative colitis often present with life threatening GIB.
The etiology of LGIB is very different between children and adults, and its incidence is agedependent. The main causes of LGIB in adults are colorectal cancer, colorectal polyps, anorectal disease and inflammatory bowel diseases (IBDs); in children, colorectal polyps, chronic colitis and perianal lesions are the main causes [20] . In infants, allergic colitis and anorectal fissures represent the most common causes, while infectious enteritis and anorectal fissures are the most common causes in older children [21] (Table   3 ). In young infants (< 1 year of age), the most likely cause of hematochezia with or (more often) without diarrhea is the socalled allergic colitis; although CMPA is usually suspected, the etiology is often uncertain. In breastfed infants, without anemia, who are growing well, hematochezia is usually a benign selflimiting disorder, and a maternal milkfree diet is not necessarily indicated [22] . A valid approach to investigate the causes of LGIB is to classify it according to the child's age, general appearance (ill or well), bleeding rate, and stool charac teristics [23] . Meckel's diverticulum should strongly be suspected, at any age, if bleeding is massive and accompanied by both bright and dark red stools. In ill infants, ischemic/surgical causes, such as midgut volvulus and intussusception, should be suspected. In older children, other serious medical causes, such as severe attack of ulcerative colitis, HenochSchonlein purpura or hemolyticuremic syndrome, might be the cause of bleeding [24] . In cases of severe LGIB, especially when melena is present or the patient is hemodynamically unstable, the source of bleeding may include the upper gastrointestinal region [25] . In cases with bloody diarrhea that is persistent (> 7 d), recurrent or severe (> 7 bloody stools/d), the child should be seen by a pediatric gastroenterologist with indication to endoscopy. Rectal bleeding with normal stool pattern is suggestive of 1 year of age), the most prevalent causes are caustic ingestions, duplication cysts, foreign body ingestion, and medicationinduced. In toddlers and young children (1 year to 5 years of age), causes include erosive esophagitis, gastritis, caustic ingestions, peptic ulcer bleeding, varices, and vomitinginduced bleeding (e.g., from a MalloryWeiss tear). In children and adolescents (ages 5 years to 18 years), bleeding can arise from coagulation disorders, gastritis, Dieulafoy lesions (angiodysplasia), erosive esophagitis, peptic ulcer disease, caustic ingestions, and vomiting induced bleeding [10] . Crohn's disease is an uncommon cause of UGIB in the pediatric population [11] . Certain foods may create confusion by mimicking the appearance of blood in vomitus [e.g., artificial (red) foodcoloring, fruit flavored drinks, fruit juices, and beets]. All findings suspicious of blood in vomitus should be clinically inves tigated further [12] . The current diagnostic approach for pediatric UGIB has been mostly extrapolated from studies of adults; the key points are extensive historytaking and examination, laboratory evaluations, and diagnostic procedures [13] . Maternal sources of blood include ingestion of blood during the delivery or from cracked nipples during breastfeeding; infants who ingest maternal blood may present with hematemesis or melena [4] . Historical information includes the presence of abdominal pain, coffeegroundlike emesis, dys phagia, black and tarry stools, bright red blood via rectum, hematemesis, and chest pain. In addition, drug use should be elicited, especially any previous use of non-steroidal anti-inflammatory drugs (NSAIDs), aspirin and/or corticosteroids [14] . The physician should also ascertain a history of peptic ulcer bleeding or surgery, as well as any previous episodes of UGIB and previous history of umbilical catheterization [15] . In newborns with suspected UGIB, an alkali denaturation test (i.e., the AptDowney test) can differentiate neonatal blood from maternal blood. Gastric lavage via nasogastric tube can improve the accuracy of endoscopy [16, 17] . Upper endoscopy is the test of choice for evaluating hematemesis. The goals of the presence of juvenile polyp, nodular lymphoid hyperplasia or eosinophilic colitis, as well as IBD and, rarely, vascular malformations. In a retrospective crosssectional study, de Ridder et al [26] reported data of 137 children undergoing colonoscopy for rectal bleeding (mean duration of 28 wk). The diagnosis rate for first colonoscopy (IBD and colonic polyps) was 80%. No abnormalities were found in 20.4% of the patients, either by colonoscopy or histopathology, and the final diagnosis for these cases was selflimited GIB. Constipation is commonly associated with the pre sence of anal fissure and pain on defecation. Visual inspection of the perianal area as well as digital rectal examination are mandatory to detect the possibility of anal fissure, streptococcal cryptitis or rectal polyp. Endoscopy within 6 h after the first evaluation is rarely needed; in cases of severe colitis, a rapid diagnosis and histological evaluation may necessitate a procto sigmoidoscopy without bowel cleansing [23] .
In conclusion, the main priority for the physician in evaluating a patient with LGIB is to identify those patients in whom bleeding is secondary to intestinal obstruction or surgical causes. An algorithm of the diagnostic approach of LGIB is presented in Figure 2 .
PRIMARY CLINICAL MANAGEMENT
Stabilization of general conditions should precede any instrumental investigation (usually endoscopy) for children with GIB. The best clinical indicator of blood loss is orthostatic changes in heart rate and blood pressure; defined as an increase in pulse rate by 20 beats/min or a decrease in systolic blood pressure of 10 mmHg or more upon moving the patient from supine to sitting position. For any other emergency situation, the first priority should be to assess the airways, breathing and circulation of the patient [5] .
The most important aspect of the initial GIB evaluation is to determine the degree and rapidity of blood loss, and any risk factors (i.e., coagulopathy, sepsis, trauma) or associated signs (i.e., purpuric lesions, hepatosplenomegaly, jaundice, cutaneous hemangiomas, eczema) [7] . In the case of a child with no clinical impairment, it is sufficient to ensure vascular access and perform baseline tests (i.e., blood count and group, liver and kidney function, blood coagulation) as well as a preanesthesia examination. For cases of UGIB, nasogastric aspiration and saline lavage are indicated to confirm the presence of intragastric blood [27] , to determine the rate of gross bleeding, to check for ongoing or recurrent bleeding, to clear the gastric field for subsequent endoscopic visualization, to prevent aspiration of gastric contents and to prevent hepatic encephalopathy in patients with cirrhosis. Parenteral vitamin K (12 mg/dose) should be administered empirically to infants, even when results of coagulation are pending. The finding of coagulopathy with an international normalized ratio > 1.5 or abnormal partial thromboplastin time should be corrected by administration of fresh frozen plasma (10 mL/kg initially); cryoprecipitate administration may be tried in the presence of severe coagulopathy, especially if the volume of fluid has to be restricted.
In conclusion, supportive measures with stabilization of hemodynamic status, correction of any coagulation or platelet abnormalities are necessary before diagnostic procedures are undertaken.
OBSCURE GASTROINTESTINAL BLEEDING
Obscure gastrointestinal bleeding (OGIB) is defined as bleeding of unknown origin that persists or recurs after negative findings on initial evaluation using bidirectional endoscopy [28] . It can be classified as overt or occult, based on presence or absence of clinicallyevident bleeding. Obscureoccult bleeding is generally determined by a positive fecal occult blood test result and/or irondeficiency anemia [29] . Chronic occult GIB may occur anywhere in the gastrointestinal tractfrom the oral cavity to the anorectum. In most cases, the site is identified by upper endoscopy and ileocolonoscopy. Causes depend on age of presentation (i.e., infants, children, adolescents) and location of gastrointestinal tract bleeding. OGIB may be active, as with melena, hematochezia or hematemesis, or it may be inactive, showing intermittent bleeding. Similar to data from adult patients [30] , OGIB accounts for 5% of all pediatric cases of GIB, including both acute overt and chronic occult types of blood loss. In approximately 75% of OGIB cases, the lesions are [31] . Diagnostic approaches for OGIB, after negative endoscopy and colonoscopy, can require small bowel endoscopic investigation by video capsule endoscopy (VCE). Balloonassisted enteroscopy (BAE), with single or doubleballoon enteroscopy (DBE), is the second line technique, having the advantage of therapeutic as well as diagnostic properties. The diagnostic yield is very good (70%-100%), and is significantly higher when BAE is performed after a positive VCE. In a recent pediatric study of 117 children treated with DBE (total of 257 procedures), Yokoyama et al [32] found the greatest indication to be OGIB (61.9%) and a low incidence of complications (5.4%), regardless of the associated therapeutic procedures. Intraoperative enteroscopy, involving insertion of an endoscope through an incision in the midsmall intestine, is currently reserved as a last option, or if small intestinal endoscopy cannot be successfully performed. Laparoscopy and exploratory laparotomy remain important alternative diagnostic tools, for when other measures cannot identify a bleeding source in selected patients [33] .
In conclusion, it is reasonable to perform both upper endoscopy and colonoscopy in a patient with OGIB (overt or occult) to identify pathological processes that can explain symptoms or iron-deficiency anemia.
IMAGING STUDIES
Radiological imaging has played an increasingly important role in the diagnosis and management of GIB over the past 30 years. Magnetic resonance imaging has emerged as key pediatric imaging modality, preferred for its lack of ionizing radiation; it is particularly suitable for studying small bowel pathologies, and is currently the first-line modality for such. The exact source of GIB may be localized by means of nuclear scintigraphy, as well as selective angiography. In general, examination by imaging is most commonly requested after negative endoscopy results, or for indeterminate causes or locations of bleeding.
The role of interventional radiology has also in creased over the past years for the treatment of gastrointestinal hemorrhage, especially in very ill patients who are poor surgical candidates. Nuclear scintigraphy is a sensitive method for detecting GIB (used at a rate of 0.1 mL/min) and the method is more sensitive, but less specific, than angiography [34] . Although arteriographic diagnosis and therapy have been reviewed extensively in the literature describing adult cases, few experiences in children have been reported. In one published pediatric study, which involved 27 children, arteriography had an overall positive diagnostic rate of 64% and a falsenegative rate of 36%. In AGIB, the diagnosis was correct in 71% and falsely negative in 29%, while in chronic or recurrent GIB, it was correct in 55% and falsely negative in 45% [35] . The only angiographic sign that is 100% diagnostic for AGIB is contrast extravasation in the intestinal lumen. However, other angiographic signs can be useful in evaluation of some of the more common pediatric pathologies that cause GIB. One of the main advantages of angiographic diagnosis of GIB is the ability to perform transcatheter treatment after the bleeding site has been located. The two main transcatheter therapies are intraarterial vasopressin infusion and embolization. The most serious complication related to the technique is bowel infarction. Hongsakul et al [36] reported the risk factors as being failure to achieve hemostasis, hemoglobin concentration, coagulopathy, UGIB, contrast extravasation, and > 1 embolized vessel.
THERAPY
The pharmacological treatment approach to UGIB and LGIB currently includes 3 classes of drugs: acid suppression drugs, vasoactive drugs, and nonselective βblockers (NSBBs).
Acid suppression drugs
The proton pump inhibitors (PPIs) have shown benefit in treatment of ulcerbleeding or UGIB patients and to be superior to the H2antagonist. There are no differences between the 5 available PPIs: esome prazole, lansoprazole, omeprazole, pantoprazole and rabeprazole. The recommended administration route is intravenous, as a 1h infusion at a dose of 13 mg/kg to maintain 24h gastric pH > 6 in active bleeding. Dosing in children has been extrapolated from the adult literature; although, the available data suggest faster drug clearance and significant interindividual variability in pediatric patients. A metaanalysis of an adult population showed that PPI treatment, with or without endoscopic therapy, compared with placebo or an H2 receptor antagonist, reduced the risk of rebleeding and the need for surgery, but did not affect mortality [37] . Several studies showed that the rate of rebleeding, requirement of blood transfusion, and duration of hospital stay were less in PPItreated patients [38] . Moreover, PPIs were shown to be effective in the treatment of GIB in children that had developed due to NSAIDs administration [39] .
Vasoactive drugs
Vasoactive treatment should be administered as soon as possible when portal hypertension is the suspected cause of GIB. These medications are reported to stop bleeding in 75%80% of cases [40] . Three vasoactive drugs (terlipressin, somatostatin, and octreotide) control variceal bleeding by reducing portal blood flow and portal pressure [41, 42] . Terlipressin has an important systemic vaso constrictor effect, which is more noticeable on the splanchnic arteries, causing an increase in systemic vascular resistance and arterial pressure as well as a significant (approximately 20%) and sustained (up to 4 h) decrease in portal vein pressure and flux [43, 44] . Several randomized trials and metaanalyses have suggested that terlipressin provides a survival benefit, compared to placebo, to patients with variceal bleeding [45, 46] . In adults, terlipressin can be considered as the first choice, with somatostatin or octreotide as the second choice. However, many studies that have compared the clinical efficacies of different types of vasoactive drugs, each administered as monotherapy, have found no differences in mortality rates. Studies in pediatric populations have yet to show the potential superiority of terlipressin over other vasoactive agents; however, Erkek et al [47] reported a singlechild experience of its use for successful management of severe nonvariceal UGIB. Studies have shown that terlipressin has a very good safety profile, compared to vasopressin, although adverse events such as hyponatremia and seizure have been described in children (thus, necessitating monitoring of sodium levels) [48] . Octeotride is a synthetic derivative of somatostatin. It produces selective splanchnic vasoconstriction and decreases portal inflow, thereby indirectly reducing variceal blood flow. In children, intravenouslyadmi nistered octreotide is effective in decreasing AGIB. Studies of pediatric populations have demonstrated octeotride to be effective at dosages of 25 mcg/kg per hour administered by continuous infusion [49] , and that initiation with a 1h bolus may be needed, and to continue the infusion for at least 5 d in patients at risk of rebleeding seems an appropriate and rational choice [50] . However, there is limited evidence regarding the efficacy and safety of octreotide for chronic GIB in children.
NSBBs
NSBBs, such as propranolol, nadolol and carvedilol, have been widely studied in adults with portal hypertension and have been shown to reduce portal pressures by decreasing cardiac output and vasoconstricting the splanchnic vessels via blockade of ß1 and ß2 receptors; moreover, carvedilol seems to be more effective than the traditional NSBBs in reducing hepatic venous pressure gradient [51] . The pediatric experience described in the literature is limited to primary and secondary prophylaxis of variceal bleeding. No formal randomized controlled trials evaluating safety and efficacy of NSBBs in children have been published. In addition, appropriate dosing of βblockers has not been established (currently ranging from 2 mg/kg per day to 8 mg/kg per day) and it is unknown whether targeting a change in heart rate of 25% is effective in reducing portal pressures and the related risk of variceal bleeding in children. Pediatric clinical data supporting use of NSBBs in preventing a first variceal bleed are also limited, likely because there is no indication to use βblockers to prevent the formation of varices. NSBBs or endoscopic band ligation are recommended, according to the Baveno VI Consensus Workshop, for the prevention of first variceal bleeding of medium or large varices [52] .
THERAPEUTIC ENDOSCOPY
The aim of therapeutic endoscopy is to stop bleeding and prevent rebleeding. Endoscopybased diagnostic and therapeutic management is a goal of physicians treating GIB and should be performed when the patient has been stabilized, and preferably within 24 h of bleeding presentation [4, 53] . Several techniques, including injection therapy, ablative therapy and mechanical therapy, have been recommended for AGIB, each of these depending on the bleeding charac teristics, such as active, oozing or no visible bleeding vessel. In addition, each of these techniques have been adapted to upper and lower endoscopy, as well as to deep endoscopy.
Common therapies for GIB in adults and children include injection therapy with dilute epinephrine and sclerosants, ablation therapy (contact methods, such as thermocoagulation heater probe and elec trocoagulation; noncontact methods, such as argon plasma coagulation) and mechanical therapy (such as with hemoclips and band ligation) [54, 55] . Epinephrine injection arrests about 80% of nonvariceal bleeding. Multiple adult metaanalyses have demonstrated that combination therapy (epinephrine injection in conjunction with clipping or ablation therapy) is superior to epinephrine alone in reducing the risk of rebleeding to about 10% [56, 57] . The endoscopy laser and argon plasma coagulation methods can be effective therapies for GIB due to vascular abnormalities; indeed, using these, most bleeding from MalloryWeiss tears stops spontaneously. For Dieulafoy lesions, which are very rare in children, endoscopy therapy is the first choice, using clipping, electrocautery, sclerosant injection, banding methods or laser. Endoclips are currently the preferred mechanical therapy for nonvariceal GIB.
In management of acute variceal bleeding, endo scopic variceal ligation (EVL) is the treatment of choice; a metaanalysis confirmed the superiority of EVL compared with endoscopic sclerotherapy for major outcomes, such as recurrent bleeding, ulceration and stricture [5860] . For therapeutic colonoscopy, adequate fasting time and appropriate bowel preparation is recommended to facilitate the visualization of mucosal lesions.
CONCLUSION
The diagnostic approach for GIB should include exten sive historytaking and examination including laboratory evaluations and application of the available and most appropriate diagnostic procedures. Endoscopy is the method of choice for evaluating UGIB and LGIB, after stabilization and resuscitation, and within 24 h of presentation. The goals of endoscopy are to identify the site and etiology of the GIB, as well as to facilitate adequate treatment. Visual inspection of the perianal area and digital rectal examination should always be considered if a bright red blood coating is present on normal or hard stool.
In children, persistent or recurrent iron-deficiency anemia could be considered as a sign of OGIB, for which VCE is the firstline endoscopic investigation. Three vasoactive drugs (terlipressin, somatostatin, and octreotide) play a role in the control of variceal bleeding and all act by reducing portal blood flow and portal pressure. Endoscopy has a therapeutic role for polyps, ulcers, erosions, blue nevi, angiodysplasia, varices, strictures and scalloping.
